NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
Back to search
Official data from USPTO
THERAPEA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/23/2024
Trademark type
Combined
Nice classes
1, 17
Filing date
03/06/2022
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
99
Owner location
Heerlen, NL
Examiner
OESTREICHER, SALIMA PARMAR
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DSM IP Assets B.V.
Representatives
Duane M. Byers NIXON & VANDERHYE PC
Technical classification
Nice Classes
Class 1Class 17
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Polyesteramideunprocessed polyester amide polymers
Class 17
Semi-processed polysteramidesemi-processed polyester amide polymers in powderliquidpelletgranulefabricbraidmembranewoven form
Publications
History of USPTO decisions and trademark events.
23 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/22/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/22/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/22/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/17/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/05/2023
GNFR
FINAL REFUSAL E-MAILED
06/05/2023
CNFR
FINAL REFUSAL WRITTEN
06/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2023
ALIE
ASSIGNED TO LIE
04/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2022
GNRT
NON-FINAL ACTION E-MAILED
11/18/2022
CNRT
NON-FINAL ACTION WRITTEN
11/18/2022
DOCK
ASSIGNED TO EXAMINER
11/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2022
NWAP
NEW APPLICATION ENTERED
03/09/2022
Continuous trademark protection
Get notified about every new filing that threatens THERAPEA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.